US Stock MarketDetailed Quotes

OPHLY Ono Pharmaceutical (ADR)

Watchlist
  • 5.048
  • +0.068+1.37%
15min DelayTrading Apr 16 14:18 ET
7.11BMarket Cap8.86P/E (TTM)

Ono Pharmaceutical (ADR) Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
(Q1)Jun 30, 2022
(FY)Mar 31, 2022
(Q4)Mar 31, 2022
Total revenue
7.25%131.19B
26.11%138.7B
12.46%120.02B
23.75%447.19B
20.28%108.17B
25.64%122.32B
26.83%109.98B
22.16%106.72B
16.84%361.36B
20.95%89.93B
Operating revenue
7.25%131.19B
26.11%138.7B
12.46%120.02B
23.75%447.19B
20.28%108.17B
25.64%122.32B
26.83%109.98B
22.16%106.72B
16.84%361.36B
20.95%89.93B
Cost of revenue
2.07%30.7B
29.20%34.59B
12.01%30.17B
17.70%110.06B
14.85%26.28B
19.98%30.08B
17.60%26.78B
18.15%26.94B
9.28%93.51B
17.79%22.88B
Gross profit
8.94%100.49B
25.12%104.1B
12.61%89.84B
25.86%337.12B
22.13%81.89B
27.61%92.24B
30.12%83.21B
23.58%79.79B
19.73%267.85B
22.07%67.05B
Operating expense
5.96%52.9B
17.81%48.42B
16.51%48.5B
18.53%195.16B
35.83%62.52B
3.39%49.93B
15.55%41.1B
19.70%41.62B
31.32%164.65B
18.66%46.03B
Selling and administrative expenses
10.73%25.69B
13.68%24.12B
8.09%23.48B
16.13%89.49B
19.27%23.34B
16.99%23.2B
13.46%21.22B
14.62%21.73B
11.31%77.06B
-6.88%19.57B
-General and administrative expense
10.73%25.69B
13.68%24.12B
8.09%23.48B
16.13%89.49B
19.27%23.34B
16.99%23.2B
13.46%21.22B
14.62%21.73B
11.31%77.06B
-6.88%19.57B
Research and development costs
2.98%27.13B
22.58%24.78B
26.61%24.58B
25.65%95.34B
11.19%29.37B
55.78%26.35B
16.81%20.22B
27.34%19.41B
21.63%75.88B
42.50%26.42B
Other operating expenses
-62.33%165M
2,308.33%289M
-6.27%553M
-12.86%11.07B
3,531.88%10.02B
-96.23%438M
-70.00%12M
-22.37%590M
557.25%12.7B
-9.21%276M
Operating profit
12.46%47.59B
32.25%55.69B
8.35%41.35B
37.57%141.96B
-7.87%19.37B
76.37%42.32B
48.38%42.11B
28.09%38.16B
4.95%103.2B
30.28%21.03B
Net non-operating interest income expense
-60.96%406M
1,013.43%1.22B
17.27%1.03B
-14.76%1.57B
36.78%-220M
-7.39%1.04B
-385.11%-134M
-13.13%880M
-28.17%1.84B
-474.19%-348M
Non-operating interest income
27.59%1.51B
1,813.85%1.24B
9.84%1.27B
-8.56%2.48B
-60.12%69M
5.52%1.19B
-38.10%65M
-11.93%1.16B
0.63%2.71B
74.75%173M
Non-operating interest expense
662.76%1.11B
-89.95%20M
-13.62%241M
4.46%913M
-44.53%289M
--145M
243.10%199M
-7.92%279M
537.96%874M
8,583.33%521M
Other net income (expense)
Income before tax
10.69%48B
35.59%56.92B
8.55%42.38B
36.66%143.53B
-7.37%19.15B
72.63%43.36B
47.67%41.98B
26.74%39.04B
4.10%105.03B
27.38%20.68B
Income tax
19.36%11.91B
56.84%14.22B
11.01%10.56B
25.80%30.62B
-55.62%2.07B
47.06%9.98B
46.19%9.06B
42.05%9.51B
-4.14%24.34B
-35.88%4.66B
Net income
8.10%36.09B
29.74%42.7B
7.76%31.82B
39.94%112.91B
6.69%17.09B
82.08%33.39B
48.09%32.91B
22.48%29.53B
6.87%80.68B
78.68%16.02B
Net income continuous Operations
8.10%36.09B
29.74%42.7B
7.76%31.82B
39.94%112.91B
6.67%17.09B
82.08%33.39B
48.09%32.91B
22.49%29.53B
6.87%80.69B
78.67%16.02B
Minority interest income
-45.59%37M
-44.23%29M
0
14.46%190M
-84.75%18M
1,260.00%68M
420.00%52M
50.00%51M
130.56%166M
372.00%118M
Net income attributable to the parent company
8.21%36.05B
29.86%42.67B
7.94%31.82B
40.00%112.72B
7.35%17.07B
81.76%33.32B
47.92%32.86B
22.44%29.48B
6.75%80.52B
77.88%15.9B
Preferred stock dividends
Other preferred stock dividends
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
8.21%36.05B
29.86%42.67B
7.94%31.82B
40.00%112.72B
7.35%17.07B
81.76%33.32B
47.92%32.86B
22.44%29.48B
6.75%80.52B
77.88%15.9B
Basic earnings per share
11.05%25.2541
31.03%29.3904
7.93%21.7178
42.33%76.9423
7.27%11.6488
85.26%22.7411
51.20%22.4311
25.17%20.1213
7.33%54.0579
81.91%10.8589
Diluted earnings per share
11.05%25.2508
31.03%29.3904
7.94%21.7145
42.32%76.9223
7.18%11.6355
85.28%22.7377
51.24%22.4311
25.18%20.118
7.33%54.0479
81.96%10.8556
Dividend per share
0
16.19%13.5211
0
30.84%23.0849
35.82%11.4475
0
26.28%11.6375
0
5.32%17.6438
-8.09%8.4284
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022(Q1)Jun 30, 2022(FY)Mar 31, 2022(Q4)Mar 31, 2022
Total revenue 7.25%131.19B26.11%138.7B12.46%120.02B23.75%447.19B20.28%108.17B25.64%122.32B26.83%109.98B22.16%106.72B16.84%361.36B20.95%89.93B
Operating revenue 7.25%131.19B26.11%138.7B12.46%120.02B23.75%447.19B20.28%108.17B25.64%122.32B26.83%109.98B22.16%106.72B16.84%361.36B20.95%89.93B
Cost of revenue 2.07%30.7B29.20%34.59B12.01%30.17B17.70%110.06B14.85%26.28B19.98%30.08B17.60%26.78B18.15%26.94B9.28%93.51B17.79%22.88B
Gross profit 8.94%100.49B25.12%104.1B12.61%89.84B25.86%337.12B22.13%81.89B27.61%92.24B30.12%83.21B23.58%79.79B19.73%267.85B22.07%67.05B
Operating expense 5.96%52.9B17.81%48.42B16.51%48.5B18.53%195.16B35.83%62.52B3.39%49.93B15.55%41.1B19.70%41.62B31.32%164.65B18.66%46.03B
Selling and administrative expenses 10.73%25.69B13.68%24.12B8.09%23.48B16.13%89.49B19.27%23.34B16.99%23.2B13.46%21.22B14.62%21.73B11.31%77.06B-6.88%19.57B
-General and administrative expense 10.73%25.69B13.68%24.12B8.09%23.48B16.13%89.49B19.27%23.34B16.99%23.2B13.46%21.22B14.62%21.73B11.31%77.06B-6.88%19.57B
Research and development costs 2.98%27.13B22.58%24.78B26.61%24.58B25.65%95.34B11.19%29.37B55.78%26.35B16.81%20.22B27.34%19.41B21.63%75.88B42.50%26.42B
Other operating expenses -62.33%165M2,308.33%289M-6.27%553M-12.86%11.07B3,531.88%10.02B-96.23%438M-70.00%12M-22.37%590M557.25%12.7B-9.21%276M
Operating profit 12.46%47.59B32.25%55.69B8.35%41.35B37.57%141.96B-7.87%19.37B76.37%42.32B48.38%42.11B28.09%38.16B4.95%103.2B30.28%21.03B
Net non-operating interest income expense -60.96%406M1,013.43%1.22B17.27%1.03B-14.76%1.57B36.78%-220M-7.39%1.04B-385.11%-134M-13.13%880M-28.17%1.84B-474.19%-348M
Non-operating interest income 27.59%1.51B1,813.85%1.24B9.84%1.27B-8.56%2.48B-60.12%69M5.52%1.19B-38.10%65M-11.93%1.16B0.63%2.71B74.75%173M
Non-operating interest expense 662.76%1.11B-89.95%20M-13.62%241M4.46%913M-44.53%289M--145M243.10%199M-7.92%279M537.96%874M8,583.33%521M
Other net income (expense)
Income before tax 10.69%48B35.59%56.92B8.55%42.38B36.66%143.53B-7.37%19.15B72.63%43.36B47.67%41.98B26.74%39.04B4.10%105.03B27.38%20.68B
Income tax 19.36%11.91B56.84%14.22B11.01%10.56B25.80%30.62B-55.62%2.07B47.06%9.98B46.19%9.06B42.05%9.51B-4.14%24.34B-35.88%4.66B
Net income 8.10%36.09B29.74%42.7B7.76%31.82B39.94%112.91B6.69%17.09B82.08%33.39B48.09%32.91B22.48%29.53B6.87%80.68B78.68%16.02B
Net income continuous Operations 8.10%36.09B29.74%42.7B7.76%31.82B39.94%112.91B6.67%17.09B82.08%33.39B48.09%32.91B22.49%29.53B6.87%80.69B78.67%16.02B
Minority interest income -45.59%37M-44.23%29M014.46%190M-84.75%18M1,260.00%68M420.00%52M50.00%51M130.56%166M372.00%118M
Net income attributable to the parent company 8.21%36.05B29.86%42.67B7.94%31.82B40.00%112.72B7.35%17.07B81.76%33.32B47.92%32.86B22.44%29.48B6.75%80.52B77.88%15.9B
Preferred stock dividends
Other preferred stock dividends 0000000000
Net income attributable to common stockholders 8.21%36.05B29.86%42.67B7.94%31.82B40.00%112.72B7.35%17.07B81.76%33.32B47.92%32.86B22.44%29.48B6.75%80.52B77.88%15.9B
Basic earnings per share 11.05%25.254131.03%29.39047.93%21.717842.33%76.94237.27%11.648885.26%22.741151.20%22.431125.17%20.12137.33%54.057981.91%10.8589
Diluted earnings per share 11.05%25.250831.03%29.39047.94%21.714542.32%76.92237.18%11.635585.28%22.737751.24%22.431125.18%20.1187.33%54.047981.96%10.8556
Dividend per share 016.19%13.5211030.84%23.084935.82%11.4475026.28%11.637505.32%17.6438-8.09%8.4284
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg